Brian Goff's Net Worth
$11 Million
Who is Brian Goff?
Brian Goff has an estimated net worth of $11 Million. This is based on reported shares across multiple companies, which include Baxalta Inc, AGIOS PHARMACEUTICALS, INC., ALEXION PHARMACEUTICALS INC, IDENIX PHARMACEUTICALS INC, and Intellia Therapeutics, Inc..
SEC CIK
Brian Goff's CIK is 0001546216
Past Insider Trading and Trends
2015 was Brian Goff's most active year for acquiring shares with 10 total transactions. Brian Goff's most active month to acquire stocks was the month of June. 2016 was Brian Goff's most active year for disposing of shares, totalling 11 transactions. Brian Goff's most active month to dispose stocks was the month of May. 2017 saw Brian Goff paying a total of $2,178,045.00 for 36,469 shares, this is the most they've acquired in one year. In 2020 Brian Goff cashed out on 26,032 shares for a total of $3,858,724.54, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Baxalta Inc No price found
EVP and President, HematologyBrian Goff used to own units in Common Stock, par value $0.01 per share but no longer holds any shares there. In the year 2015 Brian Goff filed a total of 7 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -67.17K |
—
|
—
|
0
|
Jun 3
| |||
Form 4
| -0.40% | -267.00 |
$39.74 | -$10,610.58 | 67.03K |
Mar 7
| |||
Form 4
| +101.89% | 33.96K |
$39.33 | -$64,542.81 | 67.3K |
Mar 3 - Mar 4
| |||
Form 4
| +1.61% | 527 |
$39.00 | -$20,787.00 | 33.34K |
Feb 15
| |||
Form 4
| +0.90% | 292 |
—
|
—
| 32.6K |
Aug 11
| |||
Form 4
|
∞
| 32.31K |
—
|
—
| 32.31K |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AGIOS PHARMACEUTICALS, INC. (AGIO) Snapshot price: $43.28
Chief Executive OfficerBrian Goff owns 78,792 units of Common stock which is worth $3,410,117.76. In the year 2023 Brian Goff acquired a total of 147,482 shares in AGIOS PHARMACEUTICALS, INC., Brian also disposed a total of 68,690 shares of AGIOS PHARMACEUTICALS, INC. equalling to $2,227,845.59.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +17.26% | 11.6K |
$42.75 | -$474,140.25 | 78.79K |
Scheduled
|
Aug 8
| ||
Form 4
| +24.94% | 13.41K |
$48.84 | -$591,696.60 | 67.19K |
Scheduled
|
Jun 5
| ||
Form 4
| +8.79% | 4.34K |
$32.57 | -$135,360.92 | 53.78K |
Scheduled
|
Mar 1 - Mar 5
| ||
Form 4
| +23.43% | 9.38K |
$21.64 | -$165,221.40 | 49.44K |
Scheduled
|
Jan 20 - Jan 24
| ||
Form 4
| +50.62% | 13.46K |
$22.99 | -$277,397.34 | 40.05K |
Scheduled
|
Jan 5 - Jan 9
| ||
Form 4
| +88.88% | 12.51K |
$25.48 | -$259,335.44 | 26.59K |
Aug 8
| |||
Form 4
|
∞
| 14.08K |
$28.36 | -$324,693.64 | 14.08K |
Jun 28 - Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALEXION PHARMACEUTICALS INC No price found
EVP & Chief Commercial OfficerBrian Goff used to own units in Common Stock, par value $.0001 per share but no longer holds any shares there. In the year 2017 Brian Goff filed a total of 17 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -150.83K |
—
|
—
|
0
|
Jul 21
| |||
Form 4
| +66.32% | 60.14K |
—
|
—
| 150.83K |
Jul 14
| |||
Form 4
| -1.18% | -1.09K |
$177.00 | -$192,222.00 | 90.69K |
Jun 8
| |||
Form 4
| +36.36% | 24.47K |
—
|
—
| 91.77K |
Feb 28
| |||
Form 4
| +40.15% | 19.28K |
$157.96 | -$3,379,554.20 | 67.3K |
Dec 16
| |||
Form 4
| -3.31% | -1.64K |
$114.61 | -$188,189.62 | 48.02K |
Jun 8
| |||
Form 4
| +23.59% | 9.48K |
$90.54 | -$126,846.54 | 49.66K |
Feb 28 - Mar 2
| |||
Form 4
| -3.82% | -1.59K |
$102.97 | -$164,134.18 | 40.18K |
Feb 7
| |||
Form 4
| -3.78% | -1.64K |
$118.61 | -$194,876.23 | 41.78K |
Jun 7
| |||
Form 4
| +27.74% | 9.43K |
—
|
—
| 43.42K |
Feb 28
| |||
Form 4
| -1.93% | -670.00 |
$132.93 | -$89,063.10 | 33.99K |
Feb 28
| |||
Form 4
| -4.40% | -1.60K |
$119.57 | -$190,833.72 | 34.66K |
Feb 7
| |||
Form 4
| -4.34% | -1.65K |
$118.53 | -$194,981.85 | 36.26K |
Jun 8
| |||
Form 4
| +30.87% | 8.94K |
—
|
—
| 37.9K |
Feb 28
| |||
Form 4
| +96.77% | 14.24K |
$116.31 | -$192,027.81 | 28.96K |
Feb 6 - Feb 8
| |||
Form 4
|
∞
| 14.72K |
—
|
—
| 14.72K |
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IDENIX PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Intellia Therapeutics, Inc. (NTLA) Snapshot price: $19.75
InvestorBrian Goff owns 15,409 units of Common Stock which is worth $304,327.75. In the year 2024 Brian Goff filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 15.41K |
—
|
—
| 15.41K |
Jun 13
| |||
| No matching records found | |||||||||